Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United ... with interstitial lung disease,” said Andrew Nelsen, PharmD, Vice President, Global Medical Affairs at United Therapeutics.

Early studies in a rat pulmonary transplant model suggested BALT may accelerate rejection of ... is induced in tolerant mouse lung allografts, suggesting that such structures may be protective against ...

9, 2025 — Researchers have shown that a test called ORACLE can predict lung cancer survival at the ... in adults 30 years old and older in the United States (or 713,340 cancer cases and 262,120 ...

View United Therapeutics Corporation (UTHR) current and estimated P/E ratio data provided by Seeking Alpha.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

If you’re on the fence about investing in United Therapeutics Corporation ... Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, ...

Disorders of surfactant protein biology cause dysfunction of alveolar type 2 cells and can lead to interstitial lung disease. This study describes ... FdAT2 organoids are an attractive genetic model ...

Germo Gericke, Chief Medical Officer at Ariceum Therapeutics, said ... such as small cell lung cancer (SCLC) or Merkel Cell Carcinoma (MCC), all of which have limited treatment options and ...